teclistamab,talquetamab,daratumumab
genmab,janssen
['redirectt-1']
#eha2023 presents redirectt-1 ph1 trial (2/2) 
The Lancet Haematology is a world-leading #haematology journal publishing peer-reviewed research and reviews, opinion, and news. #hematology